Indole and azaindole inhibitors of Fructose-1,6-biphosphatase
US6294672A · kind A · utility
30Cited by
8References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 5, 2000 |
| Grant date | Sep 25, 2001 |
| Priority date | — |
| Expiry date | Jan 5, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/6561
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention is directed towards novel azaindole compounds which bind to the AMP site and are potent FBPase inhibitors. The present invention also is directed towards the clinical use of the novel FBPase inhibitors as a method of treatment or prevention of diseases responsive to lowered blood glucose levels.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.